Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

FDA Approves Clobetasol Propionate Ophthalmic Suspension for Post-Operative Pain after Ocular Surgery

Tuesday, March 05, 2024

Today Formosa Pharmaceuticals headquartered in Taiwan in partnership with AimMax Therapeutics based in the United States announced a significant milestone the US Food and Drug Administration

Medigene Expands Patent Portfolio in Japan for iM-TCR Technology Enhancing TCR-T Safety and Efficacy

Tuesday, March 05, 2024

Medigene AG has recently received a patent from the Japan Patent Office for its inducible Medigene T cell receptor a mechanism designed to regulate the efficacy and safety of its T cell receptor engineered T cell

C4 Therapeutics and Merck KGaA, Darmstadt, Germany, Team Up in Strategic Discovery Collaboration Against Critical Oncogenic Proteins

Monday, March 04, 2024

C Therapeutics Inc has announced a collaboration with Merck KGaA Darmstadt Germany operating as EMD Serono in the US and Canada to develop two targeted protein degraders

Jacobio Pharma Secures IND Approval for P53 Y220C Activator JAB-30300 in the U.S.

Saturday, March 02, 2024

Jacobio Pharma a clinicalstage oncology company focusing on targeting challenging drug sites has disclosed that the FDA has granted approval for its Investigational New Drug application concerning JAB

SciSparc Launches Clinical Trial for Autism Spectrum Disorder Treatment, Commencing Dosing Phase

Friday, March 01, 2024

SciSparc Ltd a specialized clinicalstage pharmaceutical firm focusing on therapies for central nervous system disorders and rare diseases has reported the successful manufacturing and delivery of its

Cardiff Oncology Initiates Randomized Trial for First-Line RAS-Mutated Metastatic Colorectal Cancer Treatment (CRDF-004)

Friday, March 01, 2024

Cardiff Oncology Inc a biotech company specializing in developing new therapies for various cancers using PLK inhibition has announced the dosing of the first patient in its randomized Phase trial

Recce Pharmaceuticals and Murdoch Children’s Research Institute Extend Collaborative Partnership

Friday, March 01, 2024

Recce Pharmaceuticals Ltd has announced the ongoing progress of its AntiInfective Research Unit at the Murdoch Childrens Research Institute aimed at enhancing its preclinical programs and exploring

BioLineRx Initiates First Patient Dosing in Randomized Phase 2 Combination Clinical Trial for Motixafortide in First-Line Pancreatic Cancer (PDAC)

Thursday, February 29, 2024

BioLineRx Ltd has initiated the randomized CheMoMETPANC Phase combination clinical trial representing a crucial advancement in its efforts to develop groundbreaking therapies

Arcutis and Sato Enter Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Japan

Thursday, February 29, 2024

Arcutis Biotherapeutics Inc and Sato Pharmaceutical Co Ltd have announced a strategic collaboration and licensing agreement for the development production and commercialization of topical roflumilast in Japan

QIAGEN Introduces AI-Driven Biomedical Knowledge Base for Accelerating Data-Enabled Drug Discovery

Wednesday, February 28, 2024

QIAGEN has introduced QIAGEN Biomedical KBAI a novel knowledge base powered by generative AI aimed at transforming drug discovery within the pharmaceutical and biotech sectors